COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance?
The COVID-19 vaccines currently in use have undoubtedly played the most significant role in combating the SARS-CoV-2 virus and reducing disease severity and the risk of death among those affected, especially among those with pre-existing conditions, such as diabetes. The management of blood glucose...
Main Authors: | Samson Mathews Samuel, Elizabeth Varghese, Chris R. Triggle, Dietrich Büsselberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/3/454 |
Similar Items
-
Hypoglycemia during hyperosmolar hyperglycemic crises is associated with long-term mortality
by: Tomás González-Vidal, et al.
Published: (2024-04-01) -
Hyperosmolar hyperglycemic syndrome: A comprehensive review of clinical presentation, diagnosis, and treatment strategies in hyperglycemic crises
by: Dominika Orłowska, et al.
Published: (2024-01-01) -
The Implication of Elevated Serum Myoglobin Level in Acute Diabetic Complications of Ketoacidosis and Hyperglycemic Hyperosmolar State: A Real-World Study
by: Xu C, et al.
Published: (2024-07-01) -
Risk of chronic kidney disease in patients with a hyperglycemic crisis as the initial presentation of type 2 diabetes
by: Chun-Ta Huang, et al.
Published: (2024-07-01) -
The Effect of Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic on the Metabolic Tumor Markers: A Real-World Retrospective Study
by: Wen S, et al.
Published: (2024-11-01)